18 november 2016
08.30-10.05 |
PyV & HPV & Skin Cancer |
Room 0.4 |
08.30-08.55 |
Identifying therapeutic targets in Merkel Cell Carcinoma |
|
08.55-09.20 | Developing Vaccines against pathogenic Human Polyomaviruses Christopher Buck Center for Cancer Research, NCI, NIH, Bethesda, USA |
|
Free Communication / Abstracts | Room 0.4 | |
09.20-09.35 | C. Wang Novel Strains of HPyV6 and HPyV7 Are Associated with a Pruritic and Dyskeratotic Dermatosis |
|
09.35-09.50 | C. Harwood Cutaneous squamous cell carcinoma and warts in severe combined immune deficiency: a role for human papillomavirus vaccination? |
|
09.50-10.05 |
D. Sur Analysis of Prostaglandin-Endoperoxide Synthase (PTGS)-2 Gene Polymorphisms and Risk of Cervical Cancer in a East Indian Population: A Case Control Study |
|
10.05-10.30 |
Break |
Exhibition area - Lobby |
10.30-12.05 |
Carcinogenesis I |
Room 0.4 |
10.30-10.55 |
Molecular biology of Merkel cell polyomavirus oncogenesis |
|
10.55-11.20 | HPV integration in head and neck squamous cell carcinomas: cause and consequence Ernst-Jan Speel Dept. of Pathology, Maastricht University Medical Centre, Maastricht, the Netherlands |
|
Free Communication / Abstracts | Room 0.4 | |
11.20-11.35 | S. Heuser Changed mitochondrial respiration represents a metabolic phenotype of HPV8-E7 positive keratinocytes |
|
11.35-11.50 |
M. Hufbauer |
|
11.50-12.05 | P. Di Bonito Cutaneous Human Papillomaviruses, Merkel Cell Polyomavirus and cellular miRNAs detected in skin samples of an elderly people cohort affected by actinic keratosis in Italy |
|
12.05-13.30 |
Lunch |
Exhibition area - Lobby |
13.30-15.05 |
Carcinogenesis II |
Room 0.4 |
13.30-13.55 |
Immune responses to MCC and their prognostic |
|
13.55-14.20 | Human Polyomavirus 6 in Non Melanoma Skin Cancer Axel zur Hausen Dept. of Pathology, Maastricht University Medical Centre, Maastricht, the Netherlands |
|
Free Communication / Abstracts |
Room 0.4 | |
14.20-14.35 | E. van der Meijden Primary polyomavirus infection, not reactivation, as the cause of trichodysplasia spinulosa in immunocompromised patients |
|
14.35-14.50 | C. Olivero Establishment and characterization of patient-derived tumour xenograft using skin tumours from organ transplant recipients (OTRs) |
|
14.50-15.05 | S. Lanfredini The proliferation pattern observed in the transgenic HPV8 Mouse skin in associated with LRIG1 keratinocyte stem cell expansion |
|
15.05-15.30 | Break |
Exhibition area - Lobby |
15.30-17.00 |
Closing remarks |
Room 0.4 |